Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-14

Clinical Trial Update: Comparing UroLift Experience Against Rezūm [NA]

View source ↗

Summary

A clinical trial comparing UroLift against Rezūm for benign prostatic hyperplasia; the study is currently active but not recruiting, sponsored by NeoTract, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rezūm System
  • UroLift System

Snippet

Sponsor: NeoTract, Inc. | Conditions: Benign Prostatic Hyperplasia | NA | Status: ACTIVE_NOT_RECRUITING